DAVE KAUSHIK J
Insider CIK 1522751 · AIS Executive Vice President · ATNM President, CEO and Interim CFO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ATNM Actinium Pharmaceuticals, | A Award deriv | 2017-03-14 | 2017-03-16 | 250,000 | $1.39 | $347.5K | 250,000 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | A Award deriv | 2016-04-15 | 2016-04-18 | 400,000 | $1.99 | $796.0K | 400,000 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | P Buy | 2016-04-14 | 2016-04-18 | 2,000 | $2.01 | $4.0K | 88,500 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | P Buy | 2016-04-14 | 2016-04-18 | 8,000 | $2.02 | $16.2K | 86,500 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | A Award deriv | 2015-05-07 | 2015-05-22 | 63,063 | $2.52 | $158.9K | 63,063 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | A Award deriv | 2015-05-07 | 2015-05-22 | 82,128 | $2.52 | $207.0K | 82,128 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | F Tax w/h | 2015-05-07 | 2015-05-22 | 16,000 | $2.45 | $39.2K | 73,083 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | F Tax w/h | 2015-05-07 | 2015-05-22 | 7,083 | $2.45 | $17.4K | 57,083 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | D To issuer | 2015-05-07 | 2015-05-22 | 27,501 | $2.45 | $67.4K | 57,083 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | D To issuer | 2015-05-07 | 2015-05-22 | 25,000 | $2.45 | $61.3K | 85,583 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | F Tax w/h | 2015-05-07 | 2015-05-22 | 12,500 | $2.45 | $30.6K | 85,583 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | D To issuer | 2015-05-07 | 2015-05-22 | 68,000 | $2.45 | $166.6K | 73,083 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | A Award deriv | 2015-02-18 | 2015-03-16 | 150,000 | $3.58 | $537.0K | 150,000 | SEC↗ |
| ATNM Actinium Pharmaceuticals, | A Award deriv | 2013-12-16 | 2013-12-24 | 675,000 | $6.70 | $4.52M | 675,000 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2013-06-03 | 2013-06-05 | 48,000 | — | $0 | 647,195 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2013-06-03 | 2013-06-05 | 48,000 | $4.01 | $192.5K | 265,028 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2013-06-03 | 2013-06-05 | 48,000 | $0.47 | $22.6K | 313,028 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2013-05-22 | 2013-05-24 | 52,083 | — | $0 | 695,195 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2013-05-22 | 2013-05-24 | 29,461 | — | $0 | 235,567 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2013-05-22 | 2013-05-24 | 29,461 | — | $0 | 265,028 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2013-05-06 | 2013-05-08 | 12,000 | — | $0 | 643,112 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2013-05-06 | 2013-05-08 | 12,000 | $0.47 | $5.6K | 218,106 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2013-05-06 | 2013-05-08 | 12,000 | $4.02 | $48.2K | 206,106 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2012-07-06 | 2012-07-10 | 34,112 | — | $0 | 655,112 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2012-07-06 | 2012-07-10 | 21,127 | — | $0 | 213,721 | SEC↗ |
| AIS ANTARES PHARMA, INC. | A Award deriv | 2012-05-17 | 2012-05-21 | 70,000 | — | $0 | 621,000 | SEC↗ |
| AIS ANTARES PHARMA, INC. | A Award | 2012-02-10 | 2012-02-13 | 16,887 | — | $0 | 192,594 | SEC↗ |